ArrePath
ArrePath is a biotechnology company focused on discovering novel small molecule therapeutics, particularly antibiotics, using an AI/ML-enabled imaging platform integrated throughout the drug discovery process. Their approach is at least three times more efficient than traditional methods, having identified new classes of antibiotics with novel mechanisms of action and multiple compound families active against nontuberculous mycobacteria (NTM). The company addresses urgent unmet medical needs in infectious diseases and respiratory medicine, leveraging advanced data integration and innovative strategies to optimize multiple drug properties simultaneously. ArrePath's leadership includes experienced biotech executives and scientists, and the company has secured significant non-dilutive funding and partnerships to advance its pipeline.
ArrePath
ArrePath is a biotechnology company focused on discovering novel small molecule therapeutics, particularly antibiotics, using an AI/ML-enabled imaging platform integrated throughout the drug discovery process. Their approach is at least three times more efficient than traditional methods, having identified new classes of antibiotics with novel mechanisms of action and multiple compound families active against nontuberculous mycobacteria (NTM). The company addresses urgent unmet medical needs in infectious diseases and respiratory medicine, leveraging advanced data integration and innovative strategies to optimize multiple drug properties simultaneously. ArrePath's leadership includes experienced biotech executives and scientists, and the company has secured significant non-dilutive funding and partnerships to advance its pipeline.